Accueil › Cancer du poumon non à petites cellules › Illinois › Evanston
Essais cliniques pour Cancer du poumon non à petites cellules à Evanston, IL
22 études pour Cancer du poumon non à petites cellules recherchent des participants dans et autour de Evanston (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Recrutement en coursPhase 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · à 5 mi
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
- et 1 autres
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Recrutement en coursPhase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · à 5 mi
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Recrutement en coursPhase 3
- Endeavor Health, Evanston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Recrutement en coursPhase 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Illinois Cancer Specialists, Niles · à 6 mi
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Recrutement en coursPhase 3
- Illinois Cancer Specialists, Niles · à 6 mi
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Recrutement en coursPhase 3
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Recrutement en coursPhase 2
- Illinois Cancer Specialists /ID# 274678, Niles · à 6 mi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Recrutement en coursPhase 3
- Clinical Study Site, Evanston
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Recrutement en coursPhase 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · à 6 mi
- Advocate Medical Group Oncology, Park Ridge · à 8 mi
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Recrutement en coursÉtude observationnelle
- Orchard Healthcare Research Inc., Skokie · à 2 mi
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Recrutement en coursPhase 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · à 2 mi
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Recrutement en coursPhase 3
- Research Site, Niles · à 6 mi
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Recrutement en coursPhase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · à 5 mi
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Recrutement en coursPhase 2
- Advocate Aurora Health, Park Ridge · à 8 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · à 5 mi
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Research Site, Evanston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · à 5 mi
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · à 5 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · à 5 mi
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Recrutement en coursÉtude observationnelle
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
GEMINI-NSCLC: NSCLC Biomarker Study
Recrutement en coursÉtude observationnelle
- Northwestern University, Evanston
Essais pour Cancer du poumon non à petites cellules dans d'autres villes
- Houston, TX145 études
- New York City, NY120 études
- Arlington, VA104 études
- Nashville, TN97 études
- Boston, MA90 études
- Los Angeles, CA87 études
- St. Louis, MO73 études
- Chicago, IL61 études
- Baltimore, MD60 études
- San Antonio, TX59 études
- Columbus, OH56 études
- Washington, DC55 études
Autres études à Evanston
- Cancer du poumon19 études
- Cancer du sein13 études
- Leucémie aiguë myéloïde11 études
- Obésité11 études
- Cancer colorectal10 études
- Cancer (tous types)9 études
- Surpoids9 études
- Colite ulcéreuse9 études
- Cancer de la prostate9 études
- Maladie de Crohn9 études
- Insuffisance cardiaque8 études
- Fibrillation auriculaire8 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.